The ethanol extracts of clove (Eugenia caryophyllus Bullock & Harrison) and sweet flag (Acorus calamus Linn.) were investigated for their antifungal activity in comparison with eugenol and amphotericin B (AmB) by using the National Committee for Clinical Laboratory Standards (NCCLs) M27-P broth microdilution method. Two medicinal plant extracts, eugenol and amphotericin B were used to determine their minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) against 28 clinical isolates of Candida albicans and 25 clinical isolates of Cryptococcus neoformans. The MICs of clove, sweet flag, eugenol and AmB against C. albicans were 17.41+8.64 mg/ml, 28.8+16.32 mg/ml, 12.16+4.53 mg/ml and 0.23+0.1 µg/ml respectively. The MFCs were 67.5+15.39 mg/ml, >75 mg/ml, 15.4+6.47 mg/ml and 0.47+0.21 µg/ml respectively. The same extracts and antifungal drugs which were tested against C. albicans were also tested against C. neoformans. The MICs were 2.43+0.95 mg/ml, 3.02+1.97 mg/ml, 6.28+3.4 mg/ml and 0.28+0.15 µg/ml, respectively. The MFCs were 22.22+12.71 mg/ml, 30.82+27.11 mg/ml, 10.06+4.9 mg/ml and 0.51+0.25 µg/ml respectively. The results showed that C. albicans was significantly (p<0.01) more susceptible to the extract of clove than sweet flag, whereas C. neoformans was significantly susceptible to the clove extract (p>0.05). Moreover, the extract of clove showed significantly (p<0.01) more potent inhibitory activity against C. neoformans than eugenol, while it showed significantly (p<0.01) less inhibitory activity against C. albicans than eugenol. AmB, the drug of choice for invasive infection treatment, remains as one of the most effective antifungal drugs. These data indicate that the extracts of clove and sweet flag were potential fungistatic agents against yeasts, whereas AmB and eugenol showed fungicidal effects.
INTRODUCTION
The incidence of fungal infections has increased significantly in the last 20 years (Poeta et al.,1999) . In immunocompromised patients, the emergence of candida infections with both primary drug and azole-resistance have been described (Willocks et al., 1991; Cameron et al., 1993; Pfaller et al., 1994) . Amphotericin B has been provided for the standard treatment of the most systemic fungal infections (Medoff and Kobayashi, 1980) . Unfortunately, treatment with amphotericin B, especially for long-term periods, can lead to adverse effects in patients, or to the development of resistant organisms during the course of therapy (Kovacicova et al., 2001 ). In the quest for new antifungal agents, low toxicity and broad spectrum fungicidal activities are needed for effective management of the infections.
Eugenia caryophyllus Bullock & Harrison (clove) and Acorus calamus Linn. (sweet flag) have eugenol as a major constituent. These medicinal plants have been used in traditional medicine in Thailand and certain medical applications. Both plants have been reported to possess inhibitory properties to filamentous fungi in vitro (Hitokoto et al., 1980; Tragoolpua, 1996) .
Only limited knowledge is available regarding the antifungal activities of the plant, which is also used for other technological purposes. Therefore, the aim of this study was to determine the antifungal activities of some medicinal plant extracts against clinical isolates of C. neoformans and C. albicans by using the broth microdilution method.
MATERIALS AND METHODS

Plant Material
Flowers of Eugenia caryophyllus Bullock & Harrison (clove) and rhizomes of Acorus calamus Linn. (sweet flag) were selected for study.
Plant extracts were prepared as follows. Air dried plant materials (200 g) were finely ground before being infused in 95% ethanol and sonicated in an ultrasonic bath (Bandelin Sonorex super RF 510H) for 30 min. The extracts were then filtered through Whatman filter paper No.1. The filtrate was evaporated and concentrated using a rotary vacuum evaporator (Fabry et al., 1996; Tragoolpua, 1996) . The concentrated plant material was then soaked in 10 ml 95% ethanol. Finally, the ethanolic extracts were dried, weighed and kept at -20°C in sterile bottles.
Fungal Isolation
Fifty-three clinical isolates (28 of C. albicans and 25 of C. neoformans) were isolated from oral, vaginal, urine and cerebrospinal fluid of human immunodeficiency virus (HIV) -positive or -negative patients from Maharaj Nakorn Chiang Mai and Chiang Rai regional hospital, Thailand. The reference strain, C. albicans ATCC 90028, was included in all susceptibility tests as a control. The isolates were identified according to a standard procedure (Mahon and Manuselis, 1995) and cultured on Sabouraud dextrose agar (SDA) plates (BBL, Cockeysville, Md) at 35 °C for 24-48 h to ensure optimal growth before testing.
Assay Medium (Cormican and Pfaller, 1996 ; National Committee for Clinical Laboratory Standards,1997.) RPMI 1640 powder (with L-glutamine, without bicarbonate; BIOCHOM KG, Leonorenstr.2-6. D-12247 Berlin) was prepared in distilled water and adjusted to pH 7.0 with 0.165 M morpholinopropanesulfonic acid (MOPS, Sigma). This assay medium was filter sterilized by using 0.2 µm millipore size filters (Acrodisc 32, Gelman Sciences), aliquoted and stored at 4 °C until use.
Drug and Medicinal Plant Extracts Preparation
Ten serial twofold dilutions in RPMI 1640 of AmB, eugenol and two medicinal plant extracts were prepared from stock solutions and arranged in rows, as well as a growth control well (without drug) and a purity control well, which contained yeast-free medium (Cormican and Pfaller, 1996) . Stock solutions of AmB deoxycholate (Fungizone, Squibb Industria Farmaceutica S.A., Esplugues-Barcelona, Spain) and eugenol were prepared at 16,000 µg/ml and 500 mg/ml in dimethyl sulfoxide (Sigma), respectively. The final concentration ranges used were 1.6 to 0.003 µg/ml for AmB, 50 to 0.98 mg/ml for eugenol and 75.0 to 0.15 mg/ml for both ethanol plant extracts.
Inocula Preparation
Yeast inocula were prepared as previously described (Archiesi et al., 1994; Anaissie et al., 1996; Cormican and Pfaller, 1996) . Briefly, yeast was grown on Sabouraud dextrose agar plates for 24 h (C. albicans) or 48 h (C. neoformans). For each isolate, five colonies were grown until their diameters were at least 1 mm. Then, the colonies were picked off and suspended in 0.85% saline solution. The suspension was adjusted to the turbidity of a 0.5 McFarland standard at a wavelength of 530 nm. Quantitative colony plate counts were determined on SDA to verify the inoculum size. Testing of antifungal activity was performed in 96-well round-bottomed microtitration plates (Nunc TM , Denmark). Microdilution wells were inoculated with 100 µl of yeast suspension in RPMI 1640 medium. The final inoculum concentrations were approximately 5.0 X 10 2 to 2.5 X 10 3 blastoconidia/ml for C. albicans and 5.0 X 10 3 to 2.5 X 10 4 blastoconidia/ml for C. neoformans after dilution with 100 µl of either the drug solution or extract. The inoculated plates were incubated at 35°C for 24 h for C. albicans and 72 h for C. neoformans. Two replicate plates were used for each treatment. (Cormican and Pfaller, 1996) MICs were determined after incubation for 24 and 72 h at 35°C for C. albicans and C. neoformans, respectively
Time of Reading
Endpoint Determination
Growth of yeasts in each well was estimated visually and then scored as previously described (Anaissie et al., 1996) . Briefly, 0, optically clear; 1+, slightly hazy, i.e., turbidity of more than 0-25% compared to the drug-free growth control; 2+, turbidity of more than 25 to 50% of growth control; 3+, turbidity of more than 50 to 75% of growth control; and 4+, turbidity of more than 75 to 100% of growth control.
Minimum fungicidal concentration (MFC) experiments were adapted from the method of McGinnis (1980) . Briefly, 100 µl aliquots from tubes that showed growth inhibition were plated on to SDA plates. The lowest drug concentration that yielded fewer yeast colonies was recorded as the MFC.
Statistical Analysis
Data were analyzed and treatments compared using student's t-test analysis.
RESULTS AND DISCUSSION
In this report, the various concentrations of crude ethanol extracts of clove and sweet flag, and eugenol tested were compared to the standard AmB. The results of the experiments are summarized in Tables 1 and 2 . Both medicinal plant extracts showed antifungal activities against C. albicans and C. neoformans. In table 1, the average MICs of clove, sweet flag, eugenol and AmB against C. albicans were 17.41+8.64 mg/ml, 28.8+16.32 mg/ml, 12.16+4.53 mg/ml and 0.23+0.1 µg/ml, respectively. Likewise, the same extracts, eugenol and antifungal drugs which were tested against C. albicans, were also tested against C. neoformans. The average MICs were 2.43+0.95 mg/ml, 3.02+1.97 mg/ml, 6.28+3.4 mg/ml and 0.28+0.15 µg/ml, respectively. Sweet flag showed a broad range of activity against C. albicans, whereas eugenol showed a broad range of activity against C. neoformans. Generally, the average MICs of eugenol, clove and sweet flag showed that they were less effective in inhibiting the growth of C. albicans than C. neoformans (Table 1) .
Moreover, the average MFCs of clove, sweet flag, eugenol and AmB against C. albicans were 67.5+15.39 mg/ml, >75 mg/ml, 15.4+6.47 mg/ml and 0.47+0.21 µg/ml respectively. Similarly, the MFCs against C. neoformans were 22.22+12.71 mg/ml, 30.82+27.11 mg/ml, 10.06+4.9 mg/ml and 0.51+0.25 µg/ml, respectively (Table 2) .
Studies reported by Pabla et al (1997) and Teissedre et al (2000) indicated that essential oils were natural products extracted from plant materials, which can be used as antibacterial, antifungal, antioxidant, and anti-carcinogenic agents or to preserve and give specific flavors to foods. The susceptibility of yeast to ethanol crude extracts of clove and sweet flag was expected because of eugenol, which is the major constituent of both medicinal plants. The ethanol crude extracts of both plants were fractionated by thin layer chromatography (TLC) and compared to eugenol. The data showed that the plant extracts had a component, which, like eugenol, had an Rf value of 0.4. Therefore, this result indicated that eugenol is a constituent of both plants. Eugenol is a derivative of phenol that effectively kills vegetative cells of bacteria and spores by causing membrane damage and leakage of cytoplasmic contents in the cells (Lim, 1998) , inhibition of enzyme activities and denaturation of protein (Sooksringam, 1985) .
The results showed that C. albicans was significantly (p<0.01) more susceptible to the extract of clove than sweet flag, whereas C. neoformans was significantly susceptible to the clove extract (p>0.05). Moreover, the extract of clove showed significantly (p<0.01) more potent inhibitory activity against C. neoformans than eugenol, whilst it showed significantly (p<0.01) less inhibitory activity against C. albicans than eugenol.
In conclusion, comparison of the standard antimycotic agent, amphotericin B, to the extracts showed that the latter had low antimycotic activity. However, it is important to point out that the extracts of clove and sweet flag were potential agents against yeasts whereas AmB and eugenol showed fungicidal activities.
